Clinical trial
Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in…
NCT00094016 · Teva Branded Pharmaceutical Products R&D, Inc., Industry · Completed
Key facts
| NCT number | NCT00094016 |
|---|---|
| Title | Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children |
| Official title | Safety and Efficacy Evaluation of Two Doses of HFA-Propelled Beclomethasone Dipropionate (QVAR) Versus Placebo by Breath Operated and Metered Dose Inhalers in Mild to Moderate Asthmatic Children |
| Lead sponsor | Teva Branded Pharmaceutical Products R&D, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | beclomethasone dipropionate |
| Enrollment | 440 |
| Start date | Oct 31, 2004 |
| Primary completion | Jun 30, 2006 |
| Completion | Jun 30, 2006 |
| First posted | Oct 11, 2004 |
| Last update posted | Nov 23, 2021 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: